Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02832687 · ClinicalTrials.gov registry record · Phase 4
Multi-dose Acetaminophen for Patients Undergoing General Anesthesia
A Phase 4 study, sponsored by Rutgers, The State University of New Jersey.
- Terminated
- Registry status
- Phase 4
- Development phase
- 88
- Enrollment target
NCT02832687 is a Phase 4 study that was terminated before completion, run by Rutgers, The State University of New Jersey. The registered enrollment target is 88 participants.
The verdict
NCT02832687, a Phase 4 study, was terminated before completion, sponsored by Rutgers, The State University of New Jersey.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 88 participants
- Enrollment target
Study Summary
Study Objective The aim of the proposed study is to examine the effect of Q4 hour multidose IV acetaminophen on patients' readiness for discharge. In doing so the investigators will also investigate the various factors that could potentially contribute to a patient's readiness for discharge such as overall opioid consumption, time to rescue medication, incidence of postoperative nausea and vomiting, pain scores, and perioperative stress markers and their overall correlation with IV acetaminophen intake.
Interventions
- DRUG Acetaminophen
- DRUG normal saline
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 88 participants |
| Start Date | 2017-06-19 |
| Est. Completion | 2020-12-31 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02832687
The ClinicalTrials.gov registry entry for NCT02832687 describes a study currently listed as terminated, categorized as Phase 4. The registered enrollment target is 88 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Rutgers, The State University of New Jersey, which has 413 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Acetaminophen is the first listed.
NCT02832687 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02832687 about?
NCT02832687 is a clinical study titled "Multi-dose Acetaminophen for Patients Undergoing General Anesthesia". Study Objective The aim of the proposed study is to examine the effect of Q4 hour multidose IV acetaminophen on patients' readiness for discharge. In doing so the investigators will also investigate the various factors that could potentially contribute to a patient's readiness for discharge such as ...
What is the current status of trial NCT02832687?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 88 participants. The study started on 2017-06-19. Estimated completion is 2020-12-31.
What interventions are being tested in trial NCT02832687?
The interventions under investigation include: Acetaminophen (DRUG), normal saline (DRUG).
Who is sponsoring clinical trial NCT02832687?
This trial is sponsored by Rutgers, The State University of New Jersey, which has 413 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.